 | • レポートコード：MRC2-11QY04276 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は梨状筋症候群のグローバル市場について調査・分析したレポートです。種類別（投薬、理学療法、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別梨状筋症候群の競争状況、市場シェア ・世界の梨状筋症候群市場：種類別市場規模 2015年-2020年（投薬、理学療法、その他） ・世界の梨状筋症候群市場：種類別市場規模予測 2021年-2026年（投薬、理学療法、その他） ・世界の梨状筋症候群市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の梨状筋症候群市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の梨状筋症候群市場分析：米国、カナダ ・ヨーロッパの梨状筋症候群市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの梨状筋症候群市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の梨状筋症候群市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの梨状筋症候群市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novartis、Sanofi、Bayer、AstraZeneca、Teva Pharmaceuticals、Endo Pharmaceuticals、Omron Healthcare、DePuy Synthes、Miracle Stretch、Seirin Corporation、Nidd Valley Medical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Piriformis syndrome is a rare neuromuscular condition that is caused when the piriformis muscle compresses the sciatic nerve. The piriformis muscle is a flat, band-like muscle located in the buttock near the upper region of the hip joint. Piriformis syndrome mostly occurs in adults and can affect individuals from any field and activity levels. The common causes of piriformis syndrome are considered to be trauma, spasms, and overuse injury. Additionally, according to the National Center for Biotechnology Information (NCBI), the piriformis syndrome is more prevalent in patients with pain in the lower back.
The North American region is anticipated to dominate the market due to the existing well-established healthcare system, increasing healthcare expenditure, growing awareness about the syndrome, and rising geriatric population.
Market Analysis and Insights: Global Piriformis Syndrome Market
The global Piriformis Syndrome market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Piriformis Syndrome Scope and Market Size
Piriformis Syndrome market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Piriformis Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Novartis
Sanofi
Bayer
AstraZeneca
Teva Pharmaceuticals
Endo Pharmaceuticals
Omron Healthcare
DePuy Synthes
Miracle Stretch
Seirin Corporation
Nidd Valley Medical
Market segment by Type, the product can be split into
Medication
Physical Therapy
Others
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Piriformis Syndrome Revenue
1.4 Market by Type
1.4.1 Global Piriformis Syndrome Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Medication
1.4.3 Physical Therapy
1.4.4 Others
1.5 Market by Application
1.5.1 Global Piriformis Syndrome Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Piriformis Syndrome Market Perspective (2015-2026)
2.2 Global Piriformis Syndrome Growth Trends by Regions
2.2.1 Piriformis Syndrome Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Piriformis Syndrome Historic Market Share by Regions (2015-2020)
2.2.3 Piriformis Syndrome Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Piriformis Syndrome Market Growth Strategy
2.3.6 Primary Interviews with Key Piriformis Syndrome Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Piriformis Syndrome Players by Market Size
3.1.1 Global Top Piriformis Syndrome Players by Revenue (2015-2020)
3.1.2 Global Piriformis Syndrome Revenue Market Share by Players (2015-2020)
3.1.3 Global Piriformis Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Piriformis Syndrome Market Concentration Ratio
3.2.1 Global Piriformis Syndrome Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Piriformis Syndrome Revenue in 2019
3.3 Piriformis Syndrome Key Players Head office and Area Served
3.4 Key Players Piriformis Syndrome Product Solution and Service
3.5 Date of Enter into Piriformis Syndrome Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Piriformis Syndrome Historic Market Size by Type (2015-2020)
4.2 Global Piriformis Syndrome Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Piriformis Syndrome Market Size by Application (2015-2020)
5.2 Global Piriformis Syndrome Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Piriformis Syndrome Market Size (2015-2020)
6.2 Piriformis Syndrome Key Players in North America (2019-2020)
6.3 North America Piriformis Syndrome Market Size by Type (2015-2020)
6.4 North America Piriformis Syndrome Market Size by Application (2015-2020)
7 Europe
7.1 Europe Piriformis Syndrome Market Size (2015-2020)
7.2 Piriformis Syndrome Key Players in Europe (2019-2020)
7.3 Europe Piriformis Syndrome Market Size by Type (2015-2020)
7.4 Europe Piriformis Syndrome Market Size by Application (2015-2020)
8 China
8.1 China Piriformis Syndrome Market Size (2015-2020)
8.2 Piriformis Syndrome Key Players in China (2019-2020)
8.3 China Piriformis Syndrome Market Size by Type (2015-2020)
8.4 China Piriformis Syndrome Market Size by Application (2015-2020)
9 Japan
9.1 Japan Piriformis Syndrome Market Size (2015-2020)
9.2 Piriformis Syndrome Key Players in Japan (2019-2020)
9.3 Japan Piriformis Syndrome Market Size by Type (2015-2020)
9.4 Japan Piriformis Syndrome Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Piriformis Syndrome Market Size (2015-2020)
10.2 Piriformis Syndrome Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Piriformis Syndrome Market Size by Type (2015-2020)
10.4 Southeast Asia Piriformis Syndrome Market Size by Application (2015-2020)
11 India
11.1 India Piriformis Syndrome Market Size (2015-2020)
11.2 Piriformis Syndrome Key Players in India (2019-2020)
11.3 India Piriformis Syndrome Market Size by Type (2015-2020)
11.4 India Piriformis Syndrome Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Piriformis Syndrome Market Size (2015-2020)
12.2 Piriformis Syndrome Key Players in Central & South America (2019-2020)
12.3 Central & South America Piriformis Syndrome Market Size by Type (2015-2020)
12.4 Central & South America Piriformis Syndrome Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview
13.1.3 Novartis Piriformis Syndrome Introduction
13.1.4 Novartis Revenue in Piriformis Syndrome Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 Sanofi
13.2.1 Sanofi Company Details
13.2.2 Sanofi Business Overview
13.2.3 Sanofi Piriformis Syndrome Introduction
13.2.4 Sanofi Revenue in Piriformis Syndrome Business (2015-2020)
13.2.5 Sanofi Recent Development
13.3 Bayer
13.3.1 Bayer Company Details
13.3.2 Bayer Business Overview
13.3.3 Bayer Piriformis Syndrome Introduction
13.3.4 Bayer Revenue in Piriformis Syndrome Business (2015-2020)
13.3.5 Bayer Recent Development
13.4 AstraZeneca
13.4.1 AstraZeneca Company Details
13.4.2 AstraZeneca Business Overview
13.4.3 AstraZeneca Piriformis Syndrome Introduction
13.4.4 AstraZeneca Revenue in Piriformis Syndrome Business (2015-2020)
13.4.5 AstraZeneca Recent Development
13.5 Teva Pharmaceuticals
13.5.1 Teva Pharmaceuticals Company Details
13.5.2 Teva Pharmaceuticals Business Overview
13.5.3 Teva Pharmaceuticals Piriformis Syndrome Introduction
13.5.4 Teva Pharmaceuticals Revenue in Piriformis Syndrome Business (2015-2020)
13.5.5 Teva Pharmaceuticals Recent Development
13.6 Endo Pharmaceuticals
13.6.1 Endo Pharmaceuticals Company Details
13.6.2 Endo Pharmaceuticals Business Overview
13.6.3 Endo Pharmaceuticals Piriformis Syndrome Introduction
13.6.4 Endo Pharmaceuticals Revenue in Piriformis Syndrome Business (2015-2020)
13.6.5 Endo Pharmaceuticals Recent Development
13.7 Omron Healthcare
13.7.1 Omron Healthcare Company Details
13.7.2 Omron Healthcare Business Overview
13.7.3 Omron Healthcare Piriformis Syndrome Introduction
13.7.4 Omron Healthcare Revenue in Piriformis Syndrome Business (2015-2020)
13.7.5 Omron Healthcare Recent Development
13.8 DePuy Synthes
13.8.1 DePuy Synthes Company Details
13.8.2 DePuy Synthes Business Overview
13.8.3 DePuy Synthes Piriformis Syndrome Introduction
13.8.4 DePuy Synthes Revenue in Piriformis Syndrome Business (2015-2020)
13.8.5 DePuy Synthes Recent Development
13.9 Miracle Stretch
13.9.1 Miracle Stretch Company Details
13.9.2 Miracle Stretch Business Overview
13.9.3 Miracle Stretch Piriformis Syndrome Introduction
13.9.4 Miracle Stretch Revenue in Piriformis Syndrome Business (2015-2020)
13.9.5 Miracle Stretch Recent Development
13.10 Seirin Corporation
13.10.1 Seirin Corporation Company Details
13.10.2 Seirin Corporation Business Overview
13.10.3 Seirin Corporation Piriformis Syndrome Introduction
13.10.4 Seirin Corporation Revenue in Piriformis Syndrome Business (2015-2020)
13.10.5 Seirin Corporation Recent Development
13.11 Nidd Valley Medical
10.11.1 Nidd Valley Medical Company Details
10.11.2 Nidd Valley Medical Business Overview
10.11.3 Nidd Valley Medical Piriformis Syndrome Introduction
10.11.4 Nidd Valley Medical Revenue in Piriformis Syndrome Business (2015-2020)
10.11.5 Nidd Valley Medical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Piriformis Syndrome Key Market Segments
Table 2. Key Players Covered: Ranking by Piriformis Syndrome Revenue
Table 3. Ranking of Global Top Piriformis Syndrome Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Piriformis Syndrome Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Medication
Table 6. Key Players of Physical Therapy
Table 7. Key Players of Others
Table 8. Global Piriformis Syndrome Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Piriformis Syndrome Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Piriformis Syndrome Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Piriformis Syndrome Market Share by Regions (2015-2020)
Table 12. Global Piriformis Syndrome Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Piriformis Syndrome Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Piriformis Syndrome Market Growth Strategy
Table 18. Main Points Interviewed from Key Piriformis Syndrome Players
Table 19. Global Piriformis Syndrome Revenue by Players (2015-2020) (Million US$)
Table 20. Global Piriformis Syndrome Market Share by Players (2015-2020)
Table 21. Global Top Piriformis Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Piriformis Syndrome as of 2019)
Table 22. Global Piriformis Syndrome by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Piriformis Syndrome Product Solution and Service
Table 25. Date of Enter into Piriformis Syndrome Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Piriformis Syndrome Market Size by Type (2015-2020) (Million US$)
Table 28. Global Piriformis Syndrome Market Size Share by Type (2015-2020)
Table 29. Global Piriformis Syndrome Revenue Market Share by Type (2021-2026)
Table 30. Global Piriformis Syndrome Market Size Share by Application (2015-2020)
Table 31. Global Piriformis Syndrome Market Size by Application (2015-2020) (Million US$)
Table 32. Global Piriformis Syndrome Market Size Share by Application (2021-2026)
Table 33. North America Key Players Piriformis Syndrome Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Piriformis Syndrome Market Share (2019-2020)
Table 35. North America Piriformis Syndrome Market Size by Type (2015-2020) (Million US$)
Table 36. North America Piriformis Syndrome Market Share by Type (2015-2020)
Table 37. North America Piriformis Syndrome Market Size by Application (2015-2020) (Million US$)
Table 38. North America Piriformis Syndrome Market Share by Application (2015-2020)
Table 39. Europe Key Players Piriformis Syndrome Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Piriformis Syndrome Market Share (2019-2020)
Table 41. Europe Piriformis Syndrome Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Piriformis Syndrome Market Share by Type (2015-2020)
Table 43. Europe Piriformis Syndrome Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Piriformis Syndrome Market Share by Application (2015-2020)
Table 45. China Key Players Piriformis Syndrome Revenue (2019-2020) (Million US$)
Table 46. China Key Players Piriformis Syndrome Market Share (2019-2020)
Table 47. China Piriformis Syndrome Market Size by Type (2015-2020) (Million US$)
Table 48. China Piriformis Syndrome Market Share by Type (2015-2020)
Table 49. China Piriformis Syndrome Market Size by Application (2015-2020) (Million US$)
Table 50. China Piriformis Syndrome Market Share by Application (2015-2020)
Table 51. Japan Key Players Piriformis Syndrome Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Piriformis Syndrome Market Share (2019-2020)
Table 53. Japan Piriformis Syndrome Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Piriformis Syndrome Market Share by Type (2015-2020)
Table 55. Japan Piriformis Syndrome Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Piriformis Syndrome Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Piriformis Syndrome Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Piriformis Syndrome Market Share (2019-2020)
Table 59. Southeast Asia Piriformis Syndrome Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Piriformis Syndrome Market Share by Type (2015-2020)
Table 61. Southeast Asia Piriformis Syndrome Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Piriformis Syndrome Market Share by Application (2015-2020)
Table 63. India Key Players Piriformis Syndrome Revenue (2019-2020) (Million US$)
Table 64. India Key Players Piriformis Syndrome Market Share (2019-2020)
Table 65. India Piriformis Syndrome Market Size by Type (2015-2020) (Million US$)
Table 66. India Piriformis Syndrome Market Share by Type (2015-2020)
Table 67. India Piriformis Syndrome Market Size by Application (2015-2020) (Million US$)
Table 68. India Piriformis Syndrome Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Piriformis Syndrome Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Piriformis Syndrome Market Share (2019-2020)
Table 71. Central & South America Piriformis Syndrome Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Piriformis Syndrome Market Share by Type (2015-2020)
Table 73. Central & South America Piriformis Syndrome Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Piriformis Syndrome Market Share by Application (2015-2020)
Table 75. Novartis Company Details
Table 76. Novartis Business Overview
Table 77. Novartis Product
Table 78. Novartis Revenue in Piriformis Syndrome Business (2015-2020) (Million US$)
Table 79. Novartis Recent Development
Table 80. Sanofi Company Details
Table 81. Sanofi Business Overview
Table 82. Sanofi Product
Table 83. Sanofi Revenue in Piriformis Syndrome Business (2015-2020) (Million US$)
Table 84. Sanofi Recent Development
Table 85. Bayer Company Details
Table 86. Bayer Business Overview
Table 87. Bayer Product
Table 88. Bayer Revenue in Piriformis Syndrome Business (2015-2020) (Million US$)
Table 89. Bayer Recent Development
Table 90. AstraZeneca Company Details
Table 91. AstraZeneca Business Overview
Table 92. AstraZeneca Product
Table 93. AstraZeneca Revenue in Piriformis Syndrome Business (2015-2020) (Million US$)
Table 94. AstraZeneca Recent Development
Table 95. Teva Pharmaceuticals Company Details
Table 96. Teva Pharmaceuticals Business Overview
Table 97. Teva Pharmaceuticals Product
Table 98. Teva Pharmaceuticals Revenue in Piriformis Syndrome Business (2015-2020) (Million US$)
Table 99. Teva Pharmaceuticals Recent Development
Table 100. Endo Pharmaceuticals Company Details
Table 101. Endo Pharmaceuticals Business Overview
Table 102. Endo Pharmaceuticals Product
Table 103. Endo Pharmaceuticals Revenue in Piriformis Syndrome Business (2015-2020) (Million US$)
Table 104. Endo Pharmaceuticals Recent Development
Table 105. Omron Healthcare Company Details
Table 106. Omron Healthcare Business Overview
Table 107. Omron Healthcare Product
Table 108. Omron Healthcare Revenue in Piriformis Syndrome Business (2015-2020) (Million US$)
Table 109. Omron Healthcare Recent Development
Table 110. DePuy Synthes Business Overview
Table 111. DePuy Synthes Product
Table 112. DePuy Synthes Company Details
Table 113. DePuy Synthes Revenue in Piriformis Syndrome Business (2015-2020) (Million US$)
Table 114. DePuy Synthes Recent Development
Table 115. Miracle Stretch Company Details
Table 116. Miracle Stretch Business Overview
Table 117. Miracle Stretch Product
Table 118. Miracle Stretch Revenue in Piriformis Syndrome Business (2015-2020) (Million US$)
Table 119. Miracle Stretch Recent Development
Table 120. Seirin Corporation Company Details
Table 121. Seirin Corporation Business Overview
Table 122. Seirin Corporation Product
Table 123. Seirin Corporation Revenue in Piriformis Syndrome Business (2015-2020) (Million US$)
Table 124. Seirin Corporation Recent Development
Table 125. Nidd Valley Medical Company Details
Table 126. Nidd Valley Medical Business Overview
Table 127. Nidd Valley Medical Product
Table 128. Nidd Valley Medical Revenue in Piriformis Syndrome Business (2015-2020) (Million US$)
Table 129. Nidd Valley Medical Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Piriformis Syndrome Market Share by Type: 2020 VS 2026
Figure 2. Medication Features
Figure 3. Physical Therapy Features
Figure 4. Others Features
Figure 5. Global Piriformis Syndrome Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Piriformis Syndrome Report Years Considered
Figure 10. Global Piriformis Syndrome Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Piriformis Syndrome Market Share by Regions: 2020 VS 2026
Figure 12. Global Piriformis Syndrome Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Piriformis Syndrome Market Share by Players in 2019
Figure 15. Global Top Piriformis Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Piriformis Syndrome as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Piriformis Syndrome Revenue in 2019
Figure 17. North America Piriformis Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Piriformis Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Piriformis Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Piriformis Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Piriformis Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Piriformis Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Piriformis Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
腫瘍随伴症候群治療の世界市場（～2026年） A paraneoplastic syndrome is a rare group of disorder that is triggered by an abnormal immune system response caused by the neoplasm. This syndrome mostly occurs when cancer-fighting antibodies mistakenly attack normal cells in the nervous system. The prevalence of this disorder can be typically see…- アスペルガー症候群治療の世界市場（～2026年） The Asperger syndrome is a type of developmental disorders known as Autistic Spectrum Disorder (ASD). These disorders initiate in childhood and stay with individuals until their adult life. Children with the Asperger syndrome function better than those with autism, and they have normal intelligence …
- リウマチ性腫瘍随伴症候群治療の世界市場（～2026年） A paraneoplastic syndrome is a rare group of disorder that is triggered by an abnormal immune system response caused by the neoplasm. This syndrome mostly occurs when cancer-fighting antibodies mistakenly attack normal cells in the nervous system. The prevalence of this disorder can be typically see…
- 胸郭出口症候群治療の世界市場（～2026年） Thoracic outlet syndrome is a group of heterogeneous and disabling upper-extremity disorders that occur due to extrinsic compression of neurovascular structures between the clavicle and the first rib. There are three distinct types of thoracic outlet syndrome viz. neurogenic thoracic outlet syndrome…
- パリーロンバーグ病の世界市場（～2026年） Parry–Romberg syndrome, also known as progressive hemifacial atrophy, is a rare disease characterized by progressive shrinkage and degeneration of the tissues beneath the skin, usually on only one side of the face (hemifacial atrophy) but occasionally extending to other parts of the body. An autoimm…